Beranda › Infeksi Virus Epstein-Barr › Maryland
Uji klinis Infeksi Virus Epstein-Barr di Maryland
6 studi untuk Infeksi Virus Epstein-Barr mencari peserta di lokasi di Maryland.
Teks studi resmi (Bahasa Inggris)
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03258567Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 29 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06908096Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05389423A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05592626Genetic Studies of Chronic Active Epstein-Barr Disease
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 1 hingga 120 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT00032513EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
- Johns Hopkins, Baltimore
Menerima pesertaFase 2
1 Month – 79 Years · Semua jenis kelamin · Diperbarui 8 Agu 2025 · NCT03266653Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.